4.7 Article

Global microRNA depletion suppresses tumor angiogenesis

期刊

GENES & DEVELOPMENT
卷 28, 期 10, 页码 1054-1067

出版社

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/gad.239681.114

关键词

microRNA; Dicer; angiogenesis; hypoxia; CRISPR/Cas9; gene regulation

资金

  1. Swedish Research Council
  2. National Institutes of Health [R01-CA133404, EB016101-01A1, EB006365]
  3. Massachusetts Institute of Technology-Harvard Center for Cancer Nanotechnology Excellence [U54 CA151884]
  4. National Cancer Institute
  5. Koch Institute Support (core) [P30-CA14051]
  6. Damon Runyon Cancer Research Fellow [DRG-2117-12]

向作者/读者索取更多资源

MicroRNAs delicately regulate the balance of angiogenesis. Here we show that depletion of all microRNAs suppresses tumor angiogenesis. We generated microRNA-deficient tumors by knocking out Dicer1. These tumors are highly hypoxic but poorly vascularized, suggestive of deficient angiogenesis signaling. Expression profiling revealed that angiogenesis genes were significantly down-regulated as a result of the microRNA deficiency. Factor inhibiting hypoxia-inducible factor 1 (HIF-1), FIH1, is derepressed under these conditions and suppresses HIF transcription. Knocking out FIH1 using CRISPR/Cas9-mediated genome engineering reversed the phenotypes of microRNA-deficient cells in HIF transcriptional activity, VEGF production, tumor hypoxia, and tumor angiogenesis. Using multiplexed CRISPR/Cas9, we deleted regions in FIH1 39 untranslated regions (UTRs) that contain microRNA-binding sites, which derepresses FIH1 protein and represses hypoxia response. These data suggest that microRNAs promote tumor responses to hypoxia and angiogenesis by repressing FIH1.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据